Cargando…
HSCCC-based strategy for preparative separation of in vivo metabolites after administration of an herbal medicine: Saussurea laniceps, a case study
This paper reports a novel strategy based on high-speed counter-current chromatography (HSCCC) technique to separate in vivo metabolites from refined extract of urine after administration of an herbal medicine. Saussurea laniceps (SL) was chosen as a model herbal medicine to be used to test the feas...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020495/ https://www.ncbi.nlm.nih.gov/pubmed/27618988 http://dx.doi.org/10.1038/srep33036 |
_version_ | 1782453213980524544 |
---|---|
author | Yi, Tao Zhu, Lin Zhu, Guo-Yuan Tang, Yi-Na Xu, Jun Fan, Jia-Yi Zhao, Zhong-Zhen Chen, Hu-Biao |
author_facet | Yi, Tao Zhu, Lin Zhu, Guo-Yuan Tang, Yi-Na Xu, Jun Fan, Jia-Yi Zhao, Zhong-Zhen Chen, Hu-Biao |
author_sort | Yi, Tao |
collection | PubMed |
description | This paper reports a novel strategy based on high-speed counter-current chromatography (HSCCC) technique to separate in vivo metabolites from refined extract of urine after administration of an herbal medicine. Saussurea laniceps (SL) was chosen as a model herbal medicine to be used to test the feasibility of our proposed strategy. This strategy succeeded in the case of separating four in vivo metabolites of SL from the urine of rats. Briefly, after oral administration of SL extract to three rats for ten days (2.0 g/kg/d), 269.1 mg of umbelliferone glucuronide (M1, purity, 92.5%), 432.5 mg of scopoletin glucuronide (M2, purity, 93.2%), 221.4 mg of scopoletin glucuronide (M3, purity, 92.9%) and 319.0 mg of scopoletin glucuronide (M4, purity, 90.4%) were separated from 420 mL of the rat urine by HSCCC using a two-phase solvent system composed of methyl tert-butyl ether–n-butanol–acetonitrile–water (MTBE–n-BuOH–ACN–H(2)O) at a volume ratio of 10:30:11:49. The chemical structures of the four metabolites, M1 to M4, were confirmed by MS and (1)H, (13)C NMR. As far as we know, this is the first report of the successful separation of in vivo metabolites by HSCCC after administration of an herbal medicine. |
format | Online Article Text |
id | pubmed-5020495 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-50204952016-09-20 HSCCC-based strategy for preparative separation of in vivo metabolites after administration of an herbal medicine: Saussurea laniceps, a case study Yi, Tao Zhu, Lin Zhu, Guo-Yuan Tang, Yi-Na Xu, Jun Fan, Jia-Yi Zhao, Zhong-Zhen Chen, Hu-Biao Sci Rep Article This paper reports a novel strategy based on high-speed counter-current chromatography (HSCCC) technique to separate in vivo metabolites from refined extract of urine after administration of an herbal medicine. Saussurea laniceps (SL) was chosen as a model herbal medicine to be used to test the feasibility of our proposed strategy. This strategy succeeded in the case of separating four in vivo metabolites of SL from the urine of rats. Briefly, after oral administration of SL extract to three rats for ten days (2.0 g/kg/d), 269.1 mg of umbelliferone glucuronide (M1, purity, 92.5%), 432.5 mg of scopoletin glucuronide (M2, purity, 93.2%), 221.4 mg of scopoletin glucuronide (M3, purity, 92.9%) and 319.0 mg of scopoletin glucuronide (M4, purity, 90.4%) were separated from 420 mL of the rat urine by HSCCC using a two-phase solvent system composed of methyl tert-butyl ether–n-butanol–acetonitrile–water (MTBE–n-BuOH–ACN–H(2)O) at a volume ratio of 10:30:11:49. The chemical structures of the four metabolites, M1 to M4, were confirmed by MS and (1)H, (13)C NMR. As far as we know, this is the first report of the successful separation of in vivo metabolites by HSCCC after administration of an herbal medicine. Nature Publishing Group 2016-09-13 /pmc/articles/PMC5020495/ /pubmed/27618988 http://dx.doi.org/10.1038/srep33036 Text en Copyright © 2016, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Yi, Tao Zhu, Lin Zhu, Guo-Yuan Tang, Yi-Na Xu, Jun Fan, Jia-Yi Zhao, Zhong-Zhen Chen, Hu-Biao HSCCC-based strategy for preparative separation of in vivo metabolites after administration of an herbal medicine: Saussurea laniceps, a case study |
title | HSCCC-based strategy for preparative separation of in vivo metabolites after administration of an herbal medicine: Saussurea laniceps, a case study |
title_full | HSCCC-based strategy for preparative separation of in vivo metabolites after administration of an herbal medicine: Saussurea laniceps, a case study |
title_fullStr | HSCCC-based strategy for preparative separation of in vivo metabolites after administration of an herbal medicine: Saussurea laniceps, a case study |
title_full_unstemmed | HSCCC-based strategy for preparative separation of in vivo metabolites after administration of an herbal medicine: Saussurea laniceps, a case study |
title_short | HSCCC-based strategy for preparative separation of in vivo metabolites after administration of an herbal medicine: Saussurea laniceps, a case study |
title_sort | hsccc-based strategy for preparative separation of in vivo metabolites after administration of an herbal medicine: saussurea laniceps, a case study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020495/ https://www.ncbi.nlm.nih.gov/pubmed/27618988 http://dx.doi.org/10.1038/srep33036 |
work_keys_str_mv | AT yitao hscccbasedstrategyforpreparativeseparationofinvivometabolitesafteradministrationofanherbalmedicinesaussurealanicepsacasestudy AT zhulin hscccbasedstrategyforpreparativeseparationofinvivometabolitesafteradministrationofanherbalmedicinesaussurealanicepsacasestudy AT zhuguoyuan hscccbasedstrategyforpreparativeseparationofinvivometabolitesafteradministrationofanherbalmedicinesaussurealanicepsacasestudy AT tangyina hscccbasedstrategyforpreparativeseparationofinvivometabolitesafteradministrationofanherbalmedicinesaussurealanicepsacasestudy AT xujun hscccbasedstrategyforpreparativeseparationofinvivometabolitesafteradministrationofanherbalmedicinesaussurealanicepsacasestudy AT fanjiayi hscccbasedstrategyforpreparativeseparationofinvivometabolitesafteradministrationofanherbalmedicinesaussurealanicepsacasestudy AT zhaozhongzhen hscccbasedstrategyforpreparativeseparationofinvivometabolitesafteradministrationofanherbalmedicinesaussurealanicepsacasestudy AT chenhubiao hscccbasedstrategyforpreparativeseparationofinvivometabolitesafteradministrationofanherbalmedicinesaussurealanicepsacasestudy |